1. Germany Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Merck KGaA

Merck KGaA

MKGAF
Merck KGaAUS flagOther OTC
159.12
USD
-7.48
- -
69.18BMarket Cap

Total Valuation

Merck KGaA carries a market capitalization of 69.18B, placing it among publicly traded companies globally. Its enterprise value stands at 64.70B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap69.18B
Enterprise Value64.70B

Share Statistics

Merck KGaA currently has 434.78M shares outstanding.

Shares Outstanding434.78M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Merck KGaA trades at a trailing price-to-earnings ratio of 34.47.

PE Ratio34.47
PS Ratio4.13
PB RatioN/A
P/TBV RatioN/A
P/FCF Ratio12.55
P/OCF Ratio17.87

Enterprise Valuation

On an enterprise value basis, Merck KGaA trades at an EV/EBITDA multiple of 23.94 and an EV/FCF ratio of 11.93. The EV/Sales ratio of 4.12 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 23.94 provides insight into valuation relative to core operating earnings.

EV / Sales4.12
EV / EBITDA23.94
EV / EBIT23.94
EV / FCF11.93

Financial Position

Merck KGaA maintains a current ratio of 4.47, meaning it holds 4.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 123.81, indicating elevated leverage, while an interest coverage ratio of 8.11 demonstrates adequate ability to service its debt obligations.

Current Ratio4.47
Quick Ratio1.07
Debt / Equity123.81
Debt / EBITDAN/A
Interest Coverage8.11

Financial Efficiency

Merck KGaA posts a return on equity of 13.31 and a return on invested capital of 10.86.

Return on Equity (ROE)13.31
Return on Assets (ROA)7.94
Return on Invested Capital (ROIC)10.86
Return on Capital Employed (ROCE)11.31
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.89

Taxes

Over the trailing twelve months, Merck KGaA has paid 502.00M in income taxes, reflecting an effective tax rate of 20.99.

Income Tax502.00M
Effective Tax Rate20.99

Stock Price Statistics

Merck KGaA's stock has gained approximately 19.72011% over the past 52 weeks. The 50-day moving average sits at 163.68, while the 200-day moving average is 147.88.

Beta (5Y)N/A
52-Week Price Change19.72011%
50-Day Moving Average163.68
200-Day Moving Average147.88
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Merck KGaA generated 15.70B in revenue and converted that into 1.88B in net income, yielding earnings per share of 4.34. EBITDA reached 2.70B, while operating income came in at 2.70B.

Revenue15.70B
Gross Profit9.24B
Operating Income2.70B
Pretax Income2.39B
Net Income1.88B
EBITDA2.70B
EBIT2.70B
Earnings Per Share (EPS)4.34

Cash Flow

Merck KGaA produced 3.63B in operating cash flow over the past twelve months. After subtracting -1.53B in capital expenditures, free cash flow totaled 2.09B - equivalent to 4.80 per share.

Operating Cash Flow3.63B
Capital Expenditures-1.53B
Free Cash Flow2.09B
FCF Per Share4.80

Margins

Merck KGaA operates with a gross margin of 58.84, reflecting its pricing power and cost economics. The operating margin of 17.21 and net profit margin of 11.97 provide insight into operational efficiency.

Gross Margin58.84
Operating Margin17.21
Pretax Margin15.23
Profit Margin11.97
EBITDA Margin17.21

Dividends & Yields

The company's payout ratio of 0.74 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.03
Dividend YieldN/A
Payout Ratio0.74
Shareholder Yield-3.76
FCF Yield7.97

Stock Splits

Merck KGaA's most recent stock split took place on June 30, 2014 with a 1:2 split ratio.

Last Split Date6/30/2014
Split Ratio1:2

Scores

Merck KGaA posts an Altman Z-Score of 12.37, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score12.37